Bristol-Myers Squibb (BMS) has become the latest pharmaceutical company to announce a cost-saving restructuring plan that will slash manufacturing jobs. The US drug maker will scale down in its manufacturing operations, cutting its workforce by 4800 - about 10 per cent - by 2010. The plan is projected to save ...